Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 - 2017) - MarketsandMarkets

Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 - 2017)

Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 - 2017) - MarketsandMarkets
Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 - 2017)
Published Oct 23, 2012
123 pages — Published Oct 23, 2012
Price US$ 4,650.00  |  Buy this Report Now

About This Report

  
Abstract:



Biosimulation refers to computer aided simulation of biological processes and systems, an integral part of systems biology used in drug discovery and development. This report will analyze the potential of biosimulation in drug discovery and development. Biosimulation is used across the drug discovery and development program (such as target identification, target validation, lead discovery, lead optimization, preclinical and clinical test).

The global biosimulation market was valued at $432 million in 2011 and is expected to reach $1.2 billion by 2017, at a CAGR of 18.5%. Modelling and simulation in preclinical and clinical stages contributed maximum share (60%) to the global biosimulation market in 2011.

The major driving factor for this market is the cost and time spent on drug discovery and development programs and failure of drug candidates in the late development stages. Pharmaceutical companies around the globe spent around $68 billion in 2011 in drug discovery and development programs, many of the drug discovery and development programs fail in the late stages of the clinical trials wasting all the years of efforts and money. There is a need for predictive technology which would outlay the outcome of a drug candidate in the discovery stages; biosimulation is one such technology which can bring down the cost on drug discovery and development programmes by focusing on promising lead drug candidates and experiments.

North America is the biggest market for biosimulation followed by Europe. North America which is the largest drug market in the world contributes one third for the global biosimulation market. Europe is the fastest growing market for biosimulation and the growth is attributed to the efforts of regulatory bodies in promoting new technologies in drug discovery and development. Asian market is still considered to be in development stages because of non availability of skilled workforce and infrastructure in place.

Major players in the market includes Accelrys, Schrodinger, Certara, Simulation plus, Rhenovia, ACD/Labs, CCG, LeadScope, Entelos, Genedata, Optimata among others.

  
Source:
Document ID
PH 1301
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

Title
TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 Need for new tools in drug discovery process
3.3.1.2 Increased spending on healthcare
3.3.1.3 Cost attributed to the traditional drug discovery process
3.3.1.4 Failure of drug candidates in the late development stages
3.3.1.5 Improved computational power
3.3.1.6 Improved modelling & simulation tools
3.3.2 RESTRAINTS
3.3.2.1 Unproven predictive methodology
3.3.2.2 Risk of Potential safe drug failing in biosimulation
3.3.2.3 Lack of standardization
3.3.2.4 Limited knowledge of biological systems & process
3.3.3 CHALLENGES
3.3.3.1 Increasing accuracy in prediction
3.3.3.2 Increasing collaboration/partnership among vendors & pharmaceutical companies
3.3.3.3 Integration of other technologies for better predictive models
3.3.4 TRENDS
3.3.4.1 Drug repositioning
3.3.4.2 In Patient medication
3.3.5 SWOT ANALYSIS
3.3.5.1 Strengths
3.3.5.2 Weakness
3.3.5.3 Opportunities
3.3.5.4 Threats

4 GLOBAL BIOSIMULATION MARKET, BY APPLICATION
4.1 SEGMENTATION BASED ON APPLICATIONS
4.2 APPLICATION IN DRUG DISCOVERY
4.2.1 TARGET IDENTIFICATION
4.2.1.1 Protein structure prediction
4.2.2 TARGET VALIDATION
4.2.2.1 Molecular modeling (Protein modelling software)
4.2.3 LEAD IDENTIFICATION/DISCOVERY
4.2.3.1 De novo Design
4.2.4 LEAD OPTIMIZATION
4.2.4.1 QSAR (Quantitative structure-activity relationship) Models
4.3 APPLICATION IN DRUG DEVELOPMENT
4.3.1 PRE-CLINICAL TESTING
4.3.1.1 ADME/Tox prediction
4.3.1.2 Pharmacokinetic/Pharmacodynamic (PK/PD) models (pharmacokinetic/Pharmacodymanic simulation)
4.3.2 CLINICAL TRIALS
4.3.2.1 Phase I clinical trial
4.3.2.2 Phase II clinical trial
4.3.2.3 Phase III clinical trial
4.3.3 IN PATIENT VALIDATION (HUMAN BODY SIMULAITON SOFTWARE)

5 CURRENT TRENDS &DEVELOPMENTS
5.1 MODELING AND SIMULATIONS IN PAEDIATRICS DRUG DEVELOPMENT
5.2 MODELLING & SIMULATIONS IN NEGLECTED DISEASES DRUG DEVELOPMENT (MODELS OF HUMAN DISEASES)
5.2.1 DRUG REPOSITIONING
5.2.2 GRID ENABLED DRUG DISCOVERY MODEL

6 GEOGRAPHIC ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA
6.5 REST OF THE WORLD
6.6 TRENDS IN ASIA

7 COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 PORTER'S FIVE FORCE ANALYSIS
7.3 MERGERS & ACQUISITIONS
7.4 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS & JOINT VENTURES
7.5 NEW PRODUCT LAUNCHES

8 COMPANY PROFILE
8.1 ACCELYRS, INC.
8.1.1 OVERVIEW
8.1.2 FINANCIALS
8.1.3 PRODUCTS & SERVICES
8.1.4 STRATEGY
8.1.5 DEVELOPMENTS
8.2 ADVANCED CHEMISTRY DEVELOPMENT (ACD/LABS)
8.2.1 OVERV

Table Of Contents

MarketsandMarkets—Worldwide, market research reports primarily sold for numbers, market segmentation and competitive landscape, within the business leaders.

About the Author


Cite this Report

  
MLA:
MarketsandMarkets. "Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 - 2017)" Oct 23, 2012. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/MarketsandMarkets/Global-Biosimulation-Technology-Market-For-Drug-Discovery-Development-2012-2017-2144-350>
  
APA:
MarketsandMarkets. (2012). Global Biosimulation Technology Market (For Drug Discovery & Development) (2012 - 2017) Oct 23, 2012. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/MarketsandMarkets/Global-Biosimulation-Technology-Market-For-Drug-Discovery-Development-2012-2017-2144-350>
  
US$ 4,650.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.